Merck faces Canadian suit over Fosamax
Merck & Co., the drug maker defending about 27,000 lawsuits filed by users of the painkiller Vioxx, was accused in a Canadian lawsuit of failing to warn consumers its bone drug Fosamax may damage jaw bones, a law firm said.
NEW YORK, March 31, 2006 (PRIMEZONE) -- In a unanimous decision with national significance, the New Jersey Appellate Division today upheld a trial court's decision certifying a Vioxx-related nationwide class action against Merck (NYSE:MRK), brought on behalf of third-party payors by Seeger Weiss LLP, a nationally-recognized complex class action firm. The March 31, 2006 decision is the second and Link... more...ATLANTIC CITY, N.J. (AP) --- In final pitches to the jury, lawyers for Merck & Co. and two men suing over its troubled arthritis drug Vioxx were to present summations today as the four-week trial neared a close. Link to original article